- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe
Jan 08, 2020
Cannabis Market is Heating Up Faster Than Branders Can Define It
Oct 10, 2019
OTC Drug and Dietary Supplement Market Outlook, Geographical Segmentation, Industry Size & Share, Comprehensive Analysis to 2027
Sep 09, 2020
Anti-Viral Therapies Market is expected to reach US$ 82,928.76 million in 2028
Jan 16, 2023
Vitamin K2 Market is expected to reach US$ 11,60,779.02 Thousands by 2030
Oct 11, 2023
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
Dec 24, 2019
Eye Drop Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast To 2027
Mar 17, 2021
Follow us on
